Journal
Blood Advances
Publication Date
1-9-2024
Volume
8
Issue
1
First Page
93
Last Page
98
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2023010636
Rights and Permissions
Hamadani M, Spira A, Zhou X, Liao L, Chen L, Radford J, Ai W, Solh M, Ardeshna KM, Hess B, Caimi PF, Stathis A, Carlo-Stella C, Alderuccio JP, Kahl B, Wang Y, Qin Y, Xu ZC, Zinzani PL. Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial. Blood Adv. 2024 Jan 9;8(1):93-98. doi: 10.1182/bloodadvances.2023010636. © 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Hamadani, Mehdi; Kahl, Brad; and et al., "Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial." Blood Advances. 8, 1. 93 - 98. (2024).
https://digitalcommons.wustl.edu/oa_4/3484
Additional Links
Supplemental material is available for this article at publisher site.
